4 min read
Therapeutic Thursday: The Wrong Biosimilar Costs A Decade
The biggest risk in biosimilar development isn’t making the drug but about picking the right one to copy a decade before launch.
The biggest risk in biosimilar development isn’t making the drug but about picking the right one to copy a decade before launch.